Investment trusts most highly exposed to emerging markets have been the best performers since the EU referendum on 23 June, while technology and biotech trusts have also rallied after a weak start to the year.
Figures from Numis show the winners among FTSE All Share listed trusts were those invested in Asia or emerging markets, as sentiment improved towards these regions while investors sought alternatives to UK and European markets following the Brexit vote. J. P. Morgan Asset Management led the way with four of its emerging market trusts at the top of the table. The £148m JPMorgan Chinese trust was the best overall performer with a total return in share price terms of 30.7% from 23 June to 5 September. Biotech and commodity trusts top performance tables in July This was followed by the...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
